← FDA Drug Approvals (Drugs@FDA)

SOTYKTU

NDA · New Drug Application · Sponsor: BRISTOL · Approved 2022-09-09

Drug application

FDA Application #

NDA214958

Application type

New Drug Application

Brand name

SOTYKTU

Generic name

DEUCRAVACITINIB

Active ingredients

DEUCRAVACITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL

Manufacturer

E.R. Squibb & Sons, L.L.C.

First approval

2022-09-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown